205 related articles for article (PubMed ID: 27804209)
21. Screening and diagnosis of hemoglobinopathies in Germany: Current state and future perspectives.
Aramayo-Singelmann C; Halimeh S; Proske P; Vignalingarajah A; Cario H; Christensen MO; Yamamoto R; Röth A; Reinhardt D; Reinhardt HC; Alashkar F
Sci Rep; 2022 Jun; 12(1):9762. PubMed ID: 35697769
[TBL] [Abstract][Full Text] [Related]
22. Posterior Reversible Encephalopathy Syndrome after Hematopoietic Cell Transplantation in Children with Hemoglobinopathies.
Gaziev J; Marziali S; Paciaroni K; Isgrò A; Di Giuliano F; Rossi G; Marziali M; De Angelis G; Alfieri C; Ribersani M; Andreani M; Palmieri MG; Placidi F; Romigi A; Izzi F; Floris R; Mercuri NB
Biol Blood Marrow Transplant; 2017 Sep; 23(9):1531-1540. PubMed ID: 28602890
[TBL] [Abstract][Full Text] [Related]
23. Newborn screening for sickle cell and other hemoglobinopathies: a Canadian pilot study.
Yorke D; Mitchell J; Clow C; Nuguid E; Cadogan R; Sinclair D; Luscombe S; Rozen R; Meredith P; Esseltine D
Clin Invest Med; 1992 Aug; 15(4):376-83. PubMed ID: 1516295
[TBL] [Abstract][Full Text] [Related]
24. Incidence of hemoglobinopathies and thalassemias in Northern Alberta. Establishment of reference intervals for HbF and HbA2.
Rodriguez-Capote K; Higgins TN
Clin Biochem; 2015 Jul; 48(10-11):698-702. PubMed ID: 25869492
[TBL] [Abstract][Full Text] [Related]
25. Prevention of hemoglobinopathies in Egypt.
El-Beshlawy A; Youssry I
Hemoglobin; 2009; 33 Suppl 1():S14-20. PubMed ID: 20001619
[TBL] [Abstract][Full Text] [Related]
26. Mortality of children with sickle cell disease: a population study.
Fernandes AP; Januário JN; Cangussu CB; Macedo DL; Viana MB
J Pediatr (Rio J); 2010; 86(4):279-84. PubMed ID: 20508908
[TBL] [Abstract][Full Text] [Related]
27. Population Screening for Hemoglobinopathies.
Goonasekera HW; Paththinige CS; Dissanayake VHW
Annu Rev Genomics Hum Genet; 2018 Aug; 19():355-380. PubMed ID: 29751732
[TBL] [Abstract][Full Text] [Related]
28. Klf10 Gene, a Secondary Modifier and a Pharmacogenomic Biomarker of Hydroxyurea Treatment Among Patients With Hemoglobinopathies.
Elalfy MS; El Sherif NH; Kamal TM; Aly NH
J Pediatr Hematol Oncol; 2017 Apr; 39(3):e155-e162. PubMed ID: 28085748
[TBL] [Abstract][Full Text] [Related]
29. A National Registry of Thalassemia in Turkey: Demographic and Disease Characteristics of Patients, Achievements, and Challenges in Prevention.
Aydınok Y; Oymak Y; Atabay B; Aydoğan G; Yeşilipek A; Ünal S; Kılınç Y; Oflaz B; Akın M; Vergin C; Sezgin Evim M; Çalışkan Ü; Ünal Ş; Bay A; Kazancı E; İleri T; Atay D; Patıroğlu T; Kahraman S; Söker M; Akcan M; Akdeniz A; Büyükavcı M; Alanoğlu G; Bör Ö; Soyer N; Özdemir Karadaş N; Uysalol E; Türker M; Akçay A; Ocak S; Güneş AM; Tokgöz H; Ünal E; Tiftik N; Karakaş Z
Turk J Haematol; 2018 Mar; 35(1):12-18. PubMed ID: 28404539
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of Cardiovascular Complications in Individuals with Sickle Cell Anemia and Other Hemoglobinopathies: A Systematic Review.
Lopes A; Dantas MT; Ladeia AMT
Arq Bras Cardiol; 2022 Dec; 119(6):893-899. PubMed ID: 36417618
[TBL] [Abstract][Full Text] [Related]
31. Newborn Screening for Sickle Cell Disease in Liberia: A Pilot Study.
Tubman VN; Marshall R; Jallah W; Guo D; Ma C; Ohene-Frempong K; London WB; Heeney MM
Pediatr Blood Cancer; 2016 Apr; 63(4):671-6. PubMed ID: 26739520
[TBL] [Abstract][Full Text] [Related]
32. Sickle cell disease: the Lebanese experience.
Inati A; Jradi O; Tarabay H; Moallem H; Rachkidi Y; El Accaoui R; Isma'eel H; Wehbe R; Mfarrej BG; Dabbous I; Taher A
Int J Lab Hematol; 2007 Dec; 29(6):399-408. PubMed ID: 17988293
[TBL] [Abstract][Full Text] [Related]
33. [Hemoglobinopathies in Tunisia. An updated review of the epidemiologic and molecular data].
Fattoum S
Tunis Med; 2006 Nov; 84(11):687-96. PubMed ID: 17294892
[TBL] [Abstract][Full Text] [Related]
34. [Hemoglobinopathies diagnosed at the University Hospital Ntra. Sra. de Candelaria and its area of reference in Santa Cruz de Tenerife during one year].
de las Heras Flórez S; Pérez Hernández LM
An Med Interna; 2008 Feb; 25(2):61-6. PubMed ID: 18432361
[TBL] [Abstract][Full Text] [Related]
35. [Epidemiological profile of hemoglobinopathies: a cross-sectional and descriptive index case study].
Dahmani F; Benkirane S; Kouzih J; Woumki A; Mamad H; Masrar A
Pan Afr Med J; 2017; 27():150. PubMed ID: 28904678
[TBL] [Abstract][Full Text] [Related]
36. Establishing a Sickle Cell Disease Registry in Africa: Experience From the Sickle Pan-African Research Consortium, Kumasi-Ghana.
Paintsil V; Amuzu EX; Nyanor I; Asafo-Adjei E; Mohammed AR; Yawnumah SA; Oppong-Mensah YG; Nguah SB; Obeng P; Dogbe EE; Jonas M; Nembaware V; Mazandu G; Ohene-Frempong K; Wonkam A; Makani J; Ansong D; Osei-Akoto A;
Front Genet; 2022; 13():802355. PubMed ID: 35281803
[TBL] [Abstract][Full Text] [Related]
37. Risk factors for venous thromboembolism in adults with hemoglobin SC or Sβ(+) thalassemia genotypes.
Yu TT; Nelson J; Streiff MB; Lanzkron S; Naik RP
Thromb Res; 2016 May; 141():35-8. PubMed ID: 26962984
[TBL] [Abstract][Full Text] [Related]
38. The epidemiologic transition of thalassemia and associated hemoglobinopathies in southern Taiwan.
Wang HC; Hsieh LL; Liu YC; Hsiao HH; Lin SK; Tsai WC; Liu TC
Ann Hematol; 2017 Feb; 96(2):183-188. PubMed ID: 27891555
[TBL] [Abstract][Full Text] [Related]
39. "Minor" hemoglobinopathies: a risk factor for asthma.
Palma-Carlos AG; Palma-Carlos ML; Costa AC
Eur Ann Allergy Clin Immunol; 2005 May; 37(5):177-82. PubMed ID: 15984316
[TBL] [Abstract][Full Text] [Related]
40. Distribution of thalassemias and associated hemoglobinopathies identified by prenatal diagnosis in Taiwan.
Peng CT; Liu SC; Peng YC; Lin TH; Wang SJ; Le CY; Shih MC; Tien N; Lu JJ; Lin CY
Blood Cells Mol Dis; 2013 Oct; 51(3):138-41. PubMed ID: 23689197
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
